Further analysis revealed that serum IL-12(p40), M-CSF, CCL2, and IL-23 were significantly upregulated in all MS cases, regardless of the stage or phase of the disease (Table 3, Figure 2). The gene discussed is IL9; the disease is myeloid sarcoma.